April 12, 2023

Surface Transforms: The Future of Carbon Ceramic Brakes

Surface Transforms plc (LON:SCE) is a UK-based company that designs, develops, manufactures, and sells carbon ceramic products for the brakes market in the UK and the rest of Europe. The..

Nanoco: Investing in the Future of Quantum Dots and Nanoparticles

Nanoco Group plc (LON:NANO), a company listed on the London Stock Exchange, is a market leader in the research, development, licensing, and manufacture of cadmium-free quantum dots (CFQD) and other..

Nuformix “tranilast at the heart of NXP002” in treating fibrosis (LON:NXF)

Nuformix plc (LON:NFX) Executive Director Dan Gooding caught up with DirectorsTalk discuss what the NXP002 programme is & its purpose, key findings from the results, and what’s next for the..

Anglo American De Beers sees good demand for rough diamonds in cycle 3

Anglo American plc (LON:AAL) has announced the value of rough diamond sales (Global Sightholder Sales and Auctions) for De Beers’ third sales cycle of 2023, amounting to $540 million. Cycle..

Saietta advances confidently with US & India contracts (LON:SED)

Saietta Group plc (LON:SED) Executive Chairman Tony Gott caught up with DirectorsTalk to discuss the e-drive units order from AYRO, why the deal is so important, why they chose to..

Unite Students making strong progress with 90% of rooms already sold

Unite Group plc (LON:UTG) Unite Students, the UK’s leading owner, manager and developer of student accommodation, today announces an update on current trading and quarterly property valuations for the Unite..

Enteq Technologies sells XXT for up to £3.2m

Enteq Technologies plc (LON:NTQ) the energy services technology and equipment supplier, has announced the sale of the XXT MWD (measurement while drilling) intellectual property and the associated assets. In addition,..

Cambridge Cognition awarded two contracts worth £2.1 million for rare disease trials

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won two sizeable contracts, together worth over £2.1 million, to provide the..

Poolbeg Pharma a year of substantial progress

Poolbeg Pharma Plc (LON:POLB, OTCQB: POLBF), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, has confirmed that the Company’s Annual Report and..

Search

Funds

April 12, 2023

Search

Funds

April 12, 2023

FTSE 100

Funds